Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

類似資料

• Association of early changes in (1)H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen
  著者:: Nelson, Sarah J., 等
  出版事項: (2017)
• Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM
  著者:: Essock-Burns, Emma, 等
  出版事項: (2012)
• Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme
  著者:: Li, Yan, 等
  出版事項: (2011)
• Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
  著者:: Wen, Qiuting, 等
  出版事項: (2014)
• Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor()()
  著者:: Autry, Adam, 等
  出版事項: (2017)